NewsDesk @bactiman63 Last week, the U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia...

NewsDesk @bactiman63 The antibiotic-resistant Acinetobacter baumannii bacterium is one of the most globally harmful bacteria that causes hospital-acquired infections. Researchers at the University of...

NewsDesk @bactiman63 The pathogen Acinetobacter baumannii can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now,...

By NewsDesk  @infectiousdiseasenews New research published by The Pew Charitable Trusts, University of Utah, and Infectious Diseases Society of America showed that in 2017, infections caused by six antibiotic-resistant...

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic...

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body. The...

By NewsDesk  @infectiousdiseasenews Acinetobacter outbreak at Hanna Hospital An outbreak of the drug-resistant bacterium, Acinetobacter, has been reported over a two year period at the Hanna Hospital...

Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the company has received a grant for up to $6.9 million from CARB-X (Combating...

North District Hospital or NDH is an acute general hospital serving the population of the New Territories East Cluster. Today, a spokesperson for the hospital made the following announcement: Four patients...